These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8606326)

  • 21. Efficacy, safety, and effects on quality of life of salmeterol versus albuterol in patients with mild to moderate persistent asthma.
    Wenzel SE; Lumry W; Manning M; Kalberg C; Cox F; Emmett A; Rickard K
    Ann Allergy Asthma Immunol; 1998 Jun; 80(6):463-70. PubMed ID: 9647268
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Salmeterol improves quality of life in patients with asthma requiring inhaled corticosteroids. Salmeterol Quality of Life Study Group.
    Kemp JP; Cook DA; Incaudo GA; Corren J; Kalberg C; Emmett A; Cox FM; Rickard K
    J Allergy Clin Immunol; 1998 Feb; 101(2 Pt 1):188-95. PubMed ID: 9500751
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention of exercise-induced bronchospasm in pediatric asthma patients: a comparison of salmeterol powder with albuterol.
    Blake K; Pearlman DS; Scott C; Wang Y; Stahl E; Arledge T
    Ann Allergy Asthma Immunol; 1999 Feb; 82(2):205-11. PubMed ID: 10071526
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bronchodilator response to salbutamol after chronic dosing with salmeterol or placebo.
    Langley SJ; Masterson CM; Batty EP; Woodcock A
    Eur Respir J; 1998 May; 11(5):1081-5. PubMed ID: 9648959
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Salmeterol versus theophylline in the treatment of asthma.
    Pollard SJ; Spector SL; Yancey SW; Cox FM; Emmett A
    Ann Allergy Asthma Immunol; 1997 May; 78(5):457-64. PubMed ID: 9164358
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhaled salmeterol/fluticasone propionate combination: a review of its use in persistent asthma.
    Markham A; Jarvis B
    Drugs; 2000 Nov; 60(5):1207-33. PubMed ID: 11129128
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
    Cowie RL; Boulet LP; Keith PK; Scott-Wilson CA; House KW; Dorinsky PM
    Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety of salmeterol in the maintenance treatment of asthma.
    Nathan RA; Seltzer JM; Kemp JP; Chervinsky P; Alexander WJ; Liddle R; Mills R
    Ann Allergy Asthma Immunol; 1995 Sep; 75(3):243-8. PubMed ID: 7552926
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparison of the efficacy of long-acting beta 2-agonists: eformoterol via Turbohaler and salmeterol via pressurized metered dose inhaler or Accuhaler, in mild to moderate asthmatics. Force Research Group.
    Campbell LM; Anderson TJ; Parashchak MR; Burke CM; Watson SA; Turbitt ML
    Respir Med; 1999 Apr; 93(4):236-44. PubMed ID: 10464887
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A 4-week comparison of salmeterol and terbutaline in adult asthma.
    Hermansson BA; Jenkins RJ
    Allergy; 1995 Jul; 50(7):551-8. PubMed ID: 8588686
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Case-control study of salmeterol and near-fatal attacks of asthma.
    Williams C; Crossland L; Finnerty J; Crane J; Holgate S; Pearce N; Beasley R
    Thorax; 1998 Jan; 53(1):7-13. PubMed ID: 9577515
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhaled corticosteroids plus salmeterol or montelukast: effects on resource utilization and costs.
    Stempel DA; O'Donnell JC; Meyer JW
    J Allergy Clin Immunol; 2002 Mar; 109(3):433-9. PubMed ID: 11897987
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Salmeterol: its place in asthma management.
    Kamada AK; Spahn JD; Blake KV
    Ann Pharmacother; 1994 Sep; 28(9):1100-2. PubMed ID: 7803888
    [No Abstract]   [Full Text] [Related]  

  • 34. Salmeterol xinafoate in the treatment of mild to moderate asthma in primary care. UK Study Group.
    Jones KP
    Thorax; 1994 Oct; 49(10):971-5. PubMed ID: 7974313
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bronchodilator treatment in asthma.
    Fuller RW; Castle WM; Palmer JB; Hall JR
    BMJ; 1993 Sep; 307(6905):683. PubMed ID: 8292148
    [No Abstract]   [Full Text] [Related]  

  • 36. The Salmeterol Multicenter Asthma Research Trial.
    Sears MR
    Chest; 2006 Sep; 130(3):928; author reply 928-9. PubMed ID: 16963699
    [No Abstract]   [Full Text] [Related]  

  • 37. Comparative effectiveness of budesonide-formoterol combination and fluticasone-salmeterol combination for asthma management: a United States retrospective database analysis.
    Tunceli O; Williams SA; Kern DM; Elhefni H; Pethick N; Wessman C; Zhou S; Trudo F
    J Allergy Clin Immunol Pract; 2014; 2(6):719-26. PubMed ID: 25439363
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
    Nathan RA; Rooklin A; Schoaf L; Scott C; Ellsworth A; House K; Dorinsky P
    Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Asthma group issues guidelines for safe use of salmeterol.
    Am J Health Syst Pharm; 1996 Dec; 53(24):2943-4. PubMed ID: 8974156
    [No Abstract]   [Full Text] [Related]  

  • 40. Salmeterol does not compromise the bronchodilator response to albuterol during acute episodes of asthma.
    Korosec M; Novak RD; Myers E; Skowronski M; McFadden ER
    Am J Med; 1999 Sep; 107(3):209-13. PubMed ID: 10492312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.